Aspirin may lower melanoma risk

US researchers examined diet, lifestyle and medication history from 59,806 women aged 50–79 for an average of 12 years and recorded any cases of cancer.

Data revealed the women, who were part of the Women’s Health Initiative, showed those who took more aspirin were less likely to develop melanoma.

Overall, aspirin users had a 21% lower risk than non-users. Women who had regularly been taking aspirin for five or more years were 30% less likely to develop melanoma than women who did not use aspirin.